Private Advisor Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$233K Buy
+1,306
New +$213K ﹤0.01% 2770
2021
Q3
– Sell
-1,926
Closed -$239K – 2058
2021
Q2
$239K Buy
1,926
+164
+9% +$22.1K ﹤0.01% 1749
2021
Q1
$269K Sell
1,762
-18
-1% -$2.72K ﹤0.01% 1597
2020
Q4
$229K Buy
+1,780
New +$205K ﹤0.01% 1574
2020
Q3
– Sell
-1,803
Closed -$146K – 2313
2020
Q2
$146K Buy
+1,803
New +$145K ﹤0.01% 1505
2020
Q1
– Sell
-3,780
Closed -$295K – 1511
2019
Q4
$295K Buy
+3,780
New +$272K ﹤0.01% 1283

Other funds holding GH

Private Advisor Group's GH Position: Q3 2026 in Review

Private Advisor Group opened a new position in Guardant Health (GH) in Q3 2026: 1,306 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #2770 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in GH as recently as Q2 2021.

Private Advisor Group first reported a position in GH in Q4 2019 and has held it in 6 quarters since. The position peaked at $295K in Q4 2019. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Private Advisor Group held 1,306 shares of Guardant Health worth $233K as of Q3 2026.
  • Guardant Health was a new Private Advisor Group position in Q3 2026.
  • Guardant Health made up ﹤0.01% of Private Advisor Group's portfolio in Q3 2026, its #2770 holding.
  • Private Advisor Group first reported a position in Guardant Health in Q4 2019 and has held it in 6 quarters since.
  • Private Advisor Group's Guardant Health position peaked at $295K in Q4 2019.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.